Redilev 250/500/750 250mgg, 500mg,750mg Tablets
PDF Leaflet Revision Date: 02 December 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy and adjunctive therapy for partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures.
Dosage (summary)
Starting dose: 250 mg twice daily, max: 1500 mg twice daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; monitor during pregnancy.
Key Drug Interactions
- Methotrexate
- Probenecid
- Antiepileptic medicines
Contraindications
- Hypersensitivity
- Pregnancy
- Lactation
Common side effects
- Somnolence
- Fatigue
- Headache
- Dizziness
- Nasopharyngitis
Counselling Points
- Monitor for mood changes
- Avoid driving until effects known
- Report any rash immediately
Serious warnings
- Suicidal behavior
- Serious skin reactions
- Anaphylaxis
- Withdrawal seizures
Important Disclaimer
The Redilev 250/500/750 250mgg, 500mg,750mg Tablets professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
